BioTalk Unzipped15 Des 2023

Science is Not a Conspiracy Theory

Why does developing a new medicine remain so difficult, and what happens when artificial intelligence enters the equation?

In Episode 2 of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe examine some of the fundamental challenges facing drug discovery and development, including the enormous scientific uncertainty involved in turning an idea into a medicine.

The conversation moves into artificial intelligence and its growing role in biopharmaceutical research. Gregory and Chad explore where AI could accelerate discovery and development, but also what increased reliance on AI may mean for education, critical thinking, and the way future scientists learn.

They also look beyond technology to something even more fundamental: the motivation of the scientists doing this work. What keeps people pursuing difficult scientific problems when experiments fail, companies change direction, and years of work may never become an approved therapy?

Gregory concludes the episode by sharing the unconventional path that brought him into biotechnology and pharmaceuticals.

This episode is designed for anyone curious about how medicines are developed, whether you work inside the industry or simply want to better understand the science shaping healthcare.

Chapters

00:56 - Chad Briscoe’s take on one of the greatest challenges in drug discovery and development

05:41 - A declaration about science

10:02 - The use of AI in biopharmaceutical science

15:17 - How AI may affect education and learning

16:57 - Swifties and science

17:42 - What drives scientists working toward medical progress

20:18 - Gregory’s journey into biotech and pharma

Connect with the hosts

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Resources mentioned

The Boston Society / Applied Pharmaceutical Analysis:

https://www.bostonsociety.org

Tom Shull:

https://www.linkedin.com/in/tomshull/

#biotechnology #pharmaceutical #science #drugdevelopment #drugdiscovery #research

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Jul 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Jun 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Des 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min